Log In
Print
BCIQ
Print
Print this Print this
 

NV1020

  Manage Alerts
Collapse Summary General Information
Company Catherex Inc.
DescriptionModified oncolytic herpes simplex virus (oHSV)
Molecular Target Not available
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I/II
Standard IndicationColorectal cancer
Indication DetailsTreat colorectal cancer that has metastasized to the liver
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today